Literature DB >> 1396330

Substitution of cysteine for selenocysteine in type I iodothyronine deiodinase reduces the catalytic efficiency of the protein but enhances its translation.

M J Berry1, A L Maia, J D Kieffer, J W Harney, P R Larsen.   

Abstract

Type I iodothyronine 5' deiodinase (5'DI) contains selenocysteine, encoded by a UGA codon, and this amino acid is essential for maximum catalytic efficiency in this enzyme. We recently showed that translation of UGA as selenocysteine in this protein requires a specific sequence of about 250 nucleotides in the 3' untranslated region of the messenger RNA. Translation of a 5'DI cysteine mutant does not require the 3' untranslated region. To examine both the efficiency of UGA codon recognition and the relative catalytic efficiency of selenocysteine vs. cysteine in 5'DI, we used bromoacetyl 125I-T3 labeling to quantitate transiently expressed selenocysteine (wild type) and cysteine containing type I iodothyronine deiodinases in transfected COS-7 and JEG-3 cell lines. Kinetic analyses of the same cell sonicates were performed to determine the apparent maximum velocity and Michaelis-Menten constant values for reverse T3 5' deiodination. COS-7 cells express the cysteine mutant protein at about 20-fold and JEG-3 cells about 400-fold higher levels than the selenoenzyme. However, in both cell types, the apparent catalytic constant values were at least 100-fold higher for the wild-type enzyme, compared with the cysteine mutant. These results indicate that cell lines differ markedly in their capacity to translate UGA-containing messenger RNAs. The much higher catalytic constant values for the selenium-containing enzyme illustrate the biochemical advantage of this element as compared with sulfur in the catalysis of iodothyronine deiodination.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396330     DOI: 10.1210/endo.131.4.1396330

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  38 in total

1.  Identification of a protein component of a mammalian tRNA(Sec) complex implicated in the decoding of UGA as selenocysteine.

Authors:  F Ding; P J Grabowski
Journal:  RNA       Date:  1999-12       Impact factor: 4.942

2.  Dynamics and efficiency in vivo of UGA-directed selenocysteine insertion at the ribosome.

Authors:  S Suppmann; B C Persson; A Böck
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

3.  Reconsidering the evolution of eukaryotic selenoproteins: a novel nonmammalian family with scattered phylogenetic distribution.

Authors:  Sergi Castellano; Sergey V Novoselov; Gregory V Kryukov; Alain Lescure; Enrique Blanco; Alain Krol; Vadim N Gladyshev; Roderic Guigó
Journal:  EMBO Rep       Date:  2004-01       Impact factor: 8.807

Review 4.  Ubiquitinated deiodinase: not dead yet.

Authors:  Ronald J Koenig
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

5.  Expanding the repertoire of the eukaryotic selenoproteome.

Authors:  Robert J Stillwell; Marla J Berry
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-01       Impact factor: 11.205

6.  Ubiquitination-induced conformational change within the deiodinase dimer is a switch regulating enzyme activity.

Authors:  G D Vivek Sagar; Balázs Gereben; Isabelle Callebaut; Jean-Paul Mornon; Anikó Zeöld; Wagner S da Silva; Cristina Luongo; Monica Dentice; Susana M Tente; Beatriz C G Freitas; John W Harney; Ann Marie Zavacki; Antonio C Bianco
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

7.  Regulation of the extracellular antioxidant selenoprotein plasma glutathione peroxidase (GPx-3) in mammalian cells.

Authors:  Filomena G Ottaviano; Shiow-Shih Tang; Diane E Handy; Joseph Loscalzo
Journal:  Mol Cell Biochem       Date:  2009-02-15       Impact factor: 3.396

Review 8.  Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges.

Authors:  Donald L St Germain; Valerie Anne Galton; Arturo Hernandez
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

9.  Type 3 lodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme.

Authors:  D Salvatore; S C Low; M Berry; A L Maia; J W Harney; W Croteau; D L St Germain; P R Larsen
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

10.  Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5' deiodinase deficiency.

Authors:  M J Berry; D Grieco; B A Taylor; A L Maia; J D Kieffer; W Beamer; E Glover; A Poland; P R Larsen
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.